Table 2.

Treatment characteristics and overall survival in patients with metastatic disease

	No. of patients(%)	3-Year OS(%)	Median OS		p
			Months	95%CI
Surgery
Yes	18(34)	-	-	-	-
No	35 (66)	-	-	-
Metastatic First line Chemotherapy
No chemotherapy	6(11.3)	50	20.2	0 - 40.4	0.40
Chemotherapy	47(88.7)	57.7	39	30.6 - 47.3
Chemotherapy protocol
AC 60	37(78.7)	57.7	41.4	21.6 - 61.2	0.65
FEC 100	6(12.8)	33.3	35.1	30.4 - 39.8
AT	4(8.5)	NR	39	NR
Hormonotherapy
No hormonotherapy	41(77.4)	58.3	39	27.1 -50.8	0.60
hormonotherapy	12(22.6)	48.4	35.1	5.5 - 64.8